De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation

Transplant Proc. 1993 Feb;25(1 Pt 2):1383-4.

Authors

A G Sheil¹, A P Disney, T H Mathew, N Amiss

Affiliation

¹ Australia and New Zealand Combined Dialysis and Transplant Registry, Queen Elizabeth Hospital, South Australia.

PMID: 8442150

No abstract available

MeSH terms

Australia
Azathioprine / therapeutic use
Cadaver
Cyclosporine / therapeutic use
Female
Humans
Kidney Transplantation / adverse effects*
Morbidity
Neoplasms / epidemiology*
Neoplasms / mortality
New Zealand
Prednisone / therapeutic use
Probability
Registries
Risk Factors
Skin Neoplasms / epidemiology*
Time Factors
Tissue Donors
Treatment Failure

Substances

Cyclosporine
Azathioprine
Prednisone